Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 68071-3561

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68071-3561). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3561 6)

Pdp (68071 3561 6)
Packaging label for Cyclobenzaprine Hydrochloride 10 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label describes the tablets as round, orange-yellow, debossed with '022' on one side. It lists the active ingredient strength, coloring agents, package quantity (#6 tablets), and warns of possible drowsiness and alcohol interaction. Storage instructions and manufacturer details are also present.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)
Chemical structure of cyclobenzaprine hydrochloride, showing the molecular arrangement with its core tricyclic structure and chemical formula components as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.